Literature DB >> 22612573

Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment.

Mathew J Summers1, Nichole L J Saunders.   

Abstract

OBJECTIVE: Studies of Mild Cognitive Impairment (MCI) show elevated rates of conversion to dementia at the group level. However, previous studies of the trajectory of MCI identify great heterogeneity of outcomes, with a significant proportion of individuals with MCI remaining stable over time, changing MCI subtype classification, or reverting to a normal cognitive state at long-term follow-up.
METHOD: The present study examined individual outcomes at 20 months in a group of older adults classified according to MCI subtypes. A total of 106 participants, 81 with different subtypes of MCI and 25 healthy controls, undertook longitudinal neuropsychological assessment of visual and verbal memory, attentional processing, executive functions, working memory capacity, and semantic memory.
RESULTS: At 20 months 12.3% of the MCI group progressed to dementia, 62.9% continued to meet MCI criteria, and 24.7% reverted to unimpaired levels of function. A discriminant function analysis predicted outcome at 20 months on the basis of baseline neuropsychological test performance with 86.3% accuracy. The analysis indicated that a pattern of impairments on visual episodic memory, verbal episodic memory, short-term memory, working memory, and attentional processing differentiated between participants who developed dementia, recovered from MCI, or remained in stable MCI.
CONCLUSIONS: The results of the present study raise questions regarding the specificity of existing criteria for the subtypes of MCI, with these results indicating a high degree of instability in classification over time. In addition, the results suggest that multidomain MCI is the most reliable precursor stage to the development of AD.

Entities:  

Mesh:

Year:  2012        PMID: 22612573     DOI: 10.1037/a0028576

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  42 in total

1.  Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2014-08-26       Impact factor: 2.892

2.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

3.  Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?

Authors:  Lindsay R Clark; Lisa Delano-Wood; David J Libon; Carrie R McDonald; Daniel A Nation; Katherine J Bangen; Amy J Jak; Rhoda Au; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2013-04-03       Impact factor: 2.892

4.  Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease.

Authors:  Jagan A Pillai; Aaron Bonner-Jackson; Esteban Walker; Lyla Mourany; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2014-06-04       Impact factor: 2.959

5.  Mild Cognitive Impairments Moderate the Effect of Time on Verbal Fluency Performance.

Authors:  Eleni Demetriou; Roee Holtzer
Journal:  J Int Neuropsychol Soc       Date:  2016-10-17       Impact factor: 2.892

6.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

Review 7.  Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.

Authors:  Kathryn N Devlin; Tania Giovannetti
Journal:  Neuropsychol Rev       Date:  2017-05-24       Impact factor: 7.444

8.  Elevated rates of mild cognitive impairment in HIV disease.

Authors:  David P Sheppard; Jennifer E Iudicello; Mark W Bondi; Katie L Doyle; Erin E Morgan; Paul J Massman; Paul E Gilbert; Steven Paul Woods
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

9.  The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.

Authors:  C J Brainerd; V F Reyna; R C Petersen; G E Smith; A E Kenney; C J Gross; E S Taub; B L Plassman; G G Fisher
Journal:  Neuropsychology       Date:  2013-01       Impact factor: 3.295

10.  Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.